A Novel Network Pharmacology Strategy Based on the Universal Effectiveness-Common Mechanism of Medical Herbs Uncovers Therapeutic Targets in Traumatic Brain Injury
DOI: https://doi.org/10.2147/dddt.s450895
IF: 4.3188
2024-04-16
Drug Design Development and Therapy
Abstract:Zhe Yu, 1– 3 Ruoqi Ding, 1– 3 Qiuju Yan, 1– 3 Menghan Cheng, 1– 3 Teng Li, 1– 4 Fei Zheng, 5 Lin Zhu, 1– 4 Yang Wang, 1– 4 Tao Tang, 1– 4 En Hu 1– 4 1 Institute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China; 2 NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China; 3 Center for Interdisciplinary Research in Traditional Chinese Medicine, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China; 4 Xiangya Hospital, Central South University, Nanchang, Jiangxi, 330004, People's Republic of China; 5 The College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, 410008, People's Republic of China Correspondence: En Hu; Ruoqi Ding, Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China, Email ; Purpose: Many herbs can promote neurological recovery following traumatic brain injury (TBI). There must lie a shared mechanism behind the common effectiveness. We aimed to explore the key therapeutic targets for TBI based on the common effectiveness of the medicinal plants. Material and methods: The TBI-effective herbs were retrieved from the literature as imputes of network pharmacology. Then, the active ingredients in at least two herbs were screened out as common components. The hub targets of all active compounds were identified through Cytohubba. Next, AutoDock vina was used to rank the common compound-hub target interactions by molecular docking. A highly scored compound-target pair was selected for in vivo validation. Results: We enrolled sixteen TBI-effective medicinal herbs and screened out twenty-one common compounds, such as luteolin. Ten hub targets were recognized according to the topology of the protein-protein interaction network of targets, including epidermal growth factor receptor (EGFR). Molecular docking analysis suggested that luteolin could bind strongly to the active pocket of EGFR. Administration of luteolin or the selective EGFR inhibitor AZD3759 to TBI mice promoted the recovery of body weight and neurological function, reduced astrocyte activation and EGFR expression, decreased chondroitin sulfate proteoglycans deposition, and upregulated GAP43 levels in the cortex. The effects were similar to those when treated with the selective EGFR inhibitor. Conclusion: The common effectiveness-based, common target screening strategy suggests that inhibition of EGFR can be an effective therapy for TBI. This strategy can be applied to discover core targets and therapeutic compounds in other diseases. Keywords: traditional Chinese medicine, medicinal plants, luteolin, AZD3759, epidermal growth factor receptor, astrocyte Traumatic brain injury (TBI) is a major cause of morbidity, mortality, and disability worldwide. It costs approximately $400 billion annually worldwide. However, no FDA-approved drugs are available for post-TBI improvement. Therefore, it is urgent to develop new therapies for TBI. 1 Various herbs have shown shared therapeutic effects in experimental studies of TBI. They can improve mNSS scores, reduce brain water content, and decrease neuron loss. 2 One of the possible reasons these different herbs can exert the same therapeutic effect on TBI is that they may target shared pathological mechanisms 3,4. For example, Crocus sativus L . protects the post-TBI brain from inflammatory and oxidative injury, 5 and Panax notoginseng inhibits autophagy to rescue brain damage. 6 These medicinal plants usually exert their therapeutic effects through a multiple-component and multiple-target approach. 7 Thus, we speculated that the common therapeutic effects may originate from their shared active compounds and common targets. Uncovering the shared targets and targets of these medicinal herbs will help find the core target and therapeutic ingredients for TBI. This effectiveness-directed target-discovery method can be an alternative to traditional pathophysiology-based strategies. Moreover, to a certain extent, the new approach can be more efficient due to the validated effectiveness of the imputed herbs. Network pharmacology is a systematic bioinformatics method extensively utilized to investigate the potential mechanisms of herbal medicines in diseases. 8,9 It screens active compounds, pr -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal